Dr. Brown is a Founding Managing Director at HealthCare Royalty Partners, a global healthcare investment firm. Educated as a transplantation immunologist and trained as a thoracic and vascular surgeon, Dr. Brown practiced surgery in a community setting where he also founded and led an HMO. He brings particular expertise on the technical, clinical and medical evaluation of products as well as the payor/reimbursement analysis. Dr. Brown has been involved in sourcing, conducting due diligence and closing more than $1 billion of royalty financings. In addition, he leads the firm’s European business development efforts and manages various operational functions of the firm.Previously, Dr. Brown was a partner at Paul Capital Partners, where he co-managed that firm’s royalty investments as a member of the royalty management committee. Prior to beginning his principal investment career in 2003, Dr. Brown was co-head of investment banking and head of healthcare at Adams, Harkness & Hill (now Canaccord Genuity) and a ranked biotechnology research analyst at Vector Securities International.Dr. Brown holds an AB from Yale, an MD from SUNY Upstate Medical Center and an MBA from Harvard. He currently serves on the Boards of Invuity and MonoSolRx.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Nuron Biotech | Board Member | — | — | Detail |